Home / Pharma news / Daily Qtern Tablets for Adults with Type 2 Diabetes- Approved by FDA

Daily Qtern Tablets for Adults with Type 2 Diabetes- Approved by FDA

AstraZeneca’s Qtern (dapagliflozin and saxagliptin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor and dipeptidyl peptidase-4 (DPP4) inhibitor treatment for adults with type 2 diabetes. This new combination agent is to be used alongside diet and exercise in those without adequate blood sugar control with dapagliflozin or who are already treated with dapagliflozin (Farxiga) and saxagliptin (Onglyza). FDA approved Qtern based on data from a trial looking at efficacy and safety of saxagliptin added to dapagliflozin in patients with inadequate control on metformin. cleared: https://www.drugs.com/newdrugs/fda-approves-once-daily-qtern-dapagliflozin-saxagliptin-adults-type-2-diabetes-4493.html

Check Also

A Test that can spot all types of cancers in just 10 mins !

In a major breakthrough, scientists from the University of Queensland in Australia have claimed success ...

%d bloggers like this: